Henry Ford Cancer Institute — Detroit, Michigan

Henry Ford Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Institute has participated in 29 clinical trials with 19 currently active.

Therapeutic areas: Advanced Solid Tumor, BRAF V600 Mutation, Cancer.

Sponsors: ABM Therapeutics Corporation, Scholar Rock, Inc., Iambic Therapeutics, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Institute?

Henry Ford Cancer Institute has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Institute conducted?

Henry Ford Cancer Institute has 29 clinical trials on record, with 19 currently active. Their work covers Advanced Solid Tumor, BRAF V600 Mutation, Cancer.

Is Henry Ford Cancer Institute accredited by Crixeo Clinical Trials?

Henry Ford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.